Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer

“

I hope this article leads to a greater involvement in the care of breast cancer survivors as aromatase inhibitors are long term treatments (5 years plus) and has many side effects, myalgias, arthralgias, etc.; it might help giving patients additional supplements to ameliorate those adverse events.

”